Based in the Roy J. Carver Department of Biomedical Engineering, the Mu Group integrates bioinspired principles and proteinaceous biopolymers to tackle complex respiratory and other diseases. Our mission is to translate advanced bioengineering research into tangible therapeutic benefits for patients.
